One of the things a good newsmagazine should do is provide contrasting opinions on important issues. It is something we try to achieve with nearly every article we carry.
One of the things a good newsmagazine should do is provide contrasting opinions on important issues. It is something we try to achieve with nearly every article we carry.
On rare occasions, we have the opportunity to present side-by-side contrasting viewpoints on a timely topic. This month is one of those occasions.
Beginning on page 51, you'll find a point/counterpoint presentation on the future of SPECT imaging and whether it will be supplanted by PET.
Dr. Abass Alavi and Dr. Stanley Goldsmith articulate the pro (PET) and con (SPECT) positions. The articles were commissioned by DI news editor C.P. Kaiser.
The debate is an ideal one for the June issue, which traditionally has a nuclear medicine focus and is distributed at the Society of Nuclear Medicine meeting that takes place this month.
Whether you end up agreeing with Alavi that PET is already replacing SPECT in many indications and will soon take over all of them, or with Goldsmith that SPECT will play an important role in nuclear medicine for many years to come, I think you'll find the discussion enlightening from both a clinical and an economic perspective.
I think you'll also find the discussion contains useful information for both nuclear medicine physicians and the radiologists who practice nuclear medicine on a part-time basis.
John C. Hayes is editor of Diagnostic Imaging
New Study Examines Agreement Between Radiologists and Referring Clinicians on Follow-Up Imaging
November 18th 2024Agreement on follow-up imaging was 41 percent more likely with recommendations by thoracic radiologists and 36 percent less likely on recommendations for follow-up nuclear imaging, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.